The Wistar Institute is the nation’s first independent nonprofit institution devoted exclusively to foundational biomedical research and training. Established in 1892, the institute’s notable achievement includes holding the National Cancer Institute (NCI)-designated Cancer Center status since 1972. Through a commitment to biomedical collaboration and innovation, Wistar’s research has led to breakthrough early-stage discoveries and the emergence of life science sector start-ups.
The institution’s dedicated team of scientists focuses on tackling some of the world’s most challenging problems in the field of cancer and immunology. Wistar's commitment goes beyond research as they are also involved in advancing human health through early-stage discovery and training the next generation of biomedical researchers.
It is worth noting that The Wistar Institute has received a grant investment on 14 May 2024, which signifies ongoing support and recognition for its significant contributions to the biotechnology industry. With the support of these resources, the institute is well-positioned to continue making a meaningful impact on the biomedical research landscape.
For more information, visit wistar.org and stay updated on the latest developments at The Wistar Institute.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | Unknown | - | 14 May 2024 | |
Grant | Unknown | - | 05 Aug 2022 | |
Grant | Unknown | - | 27 Jan 2022 | |
Grant | Unknown | - | 12 Sep 2019 | |
Grant | Unknown | - | 13 Mar 2015 |
No recent news or press coverage available for The Wistar Institute.